Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

about

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

Item

http://www.wikidata.org/entity/Q42061433

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

@en

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

@nl

type

Item

label

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

@en

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

@nl

prefLabel

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

@en

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

@nl

P1476

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.

@en

P2093

Adarsh Vennepureddy

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Atallah

http://www.w3.org/2001/XMLSchema#string

Terenig Terjanian

http://www.w3.org/2001/XMLSchema#string

P2860

Maintaining clarity: Review of maintenance therapy in non-small cell lung cancer

Phase II study of oral topotecan in advanced non-small cell lung cancer

Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer.

A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer.

A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3).

A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancer.

A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer.

Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.

Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial.

Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancer.

P304

429-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/WJON950E

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283833865

http://www.w3.org/2001/XMLSchema#string

P698

28983343

http://www.w3.org/2001/XMLSchema#string

P932

5624667

http://www.w3.org/2001/XMLSchema#string